Erratum to: Bioethical Inquiry DOI: 10.1007/s11673-007-9045-6 (this issue)
The Journal of Bioethical Inquiry asked Amgen for permission to re-print images of the Neulasta advertisements discussed in the article by Jane Schultz entitled Corpus Interruptus: Biotech Drugs, Insurance Providers and the Treatment of Breast Cancer. Amgen asked to see a copy of this article, and then refused to grant permission. Similar advertisements can be viewed at the following website: http://www.neulasta.com/patient/index.jsp
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s11673-007-9045-6.
Rights and permissions
About this article
Cite this article
Schultz, J.E. Corpus Interruptus: Biotech Drugs, Insurance Providers and the Treatment of Breast Cancer. Bioethical Inquiry 4, 103 (2007). https://doi.org/10.1007/s11673-007-9058-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11673-007-9058-1